Title : Synthetically lethal nanoparticles for treatment of endometrial cancer.

Pub. Date : 2018 Jan

PMID : 29203914






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our objective was to engender synthetic lethality to paclitaxel (PTX), the frontline treatment for endometrial cancer, in tumours with mutant p53 and enhance the therapeutic efficacy using polymeric nanoparticles (NPs). Paclitaxel tumor protein p53 Homo sapiens
2 Our objective was to engender synthetic lethality to paclitaxel (PTX), the frontline treatment for endometrial cancer, in tumours with mutant p53 and enhance the therapeutic efficacy using polymeric nanoparticles (NPs). Paclitaxel tumor protein p53 Homo sapiens
3 Together, our data provide compelling evidence for future studies of BIBF- and PTX-loaded NPs as a therapeutic opportunity for LOF p53 cancers. Paclitaxel tumor protein p53 Homo sapiens